Author Archives: Matt Fisher

About Matt Fisher

Matt is the chair of Mirick O'Connell's Health Law Group and a partner in the firm's Business Group. Matt focuses his practice on health law and all areas of corporate transactions. Matt's health law practice includes advising clients with regulatory, fraud, abuse, and compliance issues. With regard to regulatory matters, Matt advises clients to ensure that contracts, agreements and other business arrangements meet both federal and state statutory and regulatory requirements. Matt's regulatory advice focuses on complying with requirements of the Stark Law, Anti-Kickback Statute, fraud and abuse regulations, licensing requirements and HIPAA. Matt also advises clients on compliance policies to develop appropriate monitoring and oversight of operations.

Paying for a HIPAA Breach: Cyber Insurance Covering

A $2.3 million HIPAA settlement by 21st Century Oncology from mid-December 2017 seemed to mostly fly under the radar. A combination of events seems to have helped push the low profile, namely lack of an announcement by the Office for … Continue reading

Posted in Business, Compliance, HIPAA, Regulations | Tagged , , , , | 1 Comment

A Year of Uncertainty: Healthcare in Flux

Healthcare experienced a large degree of uncertainty and fluctuation in 2017. Almost no day passed without news of action or activity impacting the industry. All of the back and forth left healthcare buffeted and ready for a rest. Unfortunately, that … Continue reading

Posted in Accountable Care Organization, ACO, Business, Health IT, Healthcare, HIPAA, Regulations | Tagged , , , , | Leave a comment

Cost Conundrum for Value Based Care

The healthcare system is rapidly adopting alternative payment methodologies and overall moving away from the traditional fee for service system. The primary form of alternative payment is value based care, which is also broadly categorized as paying for quality as … Continue reading

Posted in Accountable Care Organization, ACO, Business, Healthcare Reform | Tagged , , , , | 2 Comments